Intrauterine Contraceptive Devices (IUCDs) Market Research Report-Forecast till 2027

Intrauterine Contraceptive Devices (IUCDs) Market Research Report: By Type (Hormonal Intrauterine Device, Copper Intrauterine Device) and By End-User (Hospitals, Gynecology Clinics, Community Health Care Centers, Others)-Forecast to 2027

ID: MRFR/HC/6977-HCR | February 2021 | Region: Global | 85 pages

Intrauterine Contraceptive Devices (IUCDs) Market Forecast


Intrauterine Contraceptive Devices (IUCDs) Market is expected to cross USD 2658.2 Million by 2025 at a CAGR of 10.5%.


Intrauterine Contraceptive Devices (IUCDs) Market Synopsis


The increasing awareness about contraceptive methods, increasing number of unintended pregnancies, and government support and initiatives for the prevention of unwanted abortions & pregnancies are set to drive the demand for intrauterine contraceptive devices (IUCDs) market during the forecast period.


Birth controls have been used since ancient times, but the safe and effective methods from the 20th century are being implemented and available. Contraceptive methods are used to prevent unwanted pregnancy by preventing the natural ovulation cycle or altering the egg fertilization process. Intrauterine contraceptive devices are placed inside the uterus to avoid pregnancy. The device has a string that ensures the correct placement of the equipment inside the uterus and helps in the removal of the device. Intrauterine contraceptive devices can be used for 3,5 and 10 years. These devices are made up of plastic and metal and available in various shapes, such as coil, loop, triangle, and T-shaped.


Strategic mergers & acquisitions and new product launches are also projected to boost intrauterine contraceptive devices (IUCDs) market growth with companies looking to strengthen their market positions, expand their product portfolios, and improves their brand images.  Many companies are working in collaboration with government and developing innovative and easy to use intrauterine contraceptive devices to strengthen its position in the global intrauterine contraceptive devices (IUCDs) market.


Market Influencer


The technological innovations are leading to effective contraception along with fewer side effects, which are strongly influencing the growth of the market and likely to provide favorable conditions for the growth of the intrauterine contraceptive devices (IUCDs) market.   


Market Drivers



  • Increasing demand for easy to use, removable, and cost-effective contraceptives is responsible for the growth of the intrauterine contraceptive devices (IUCDs) market.  

  • The growth of the intrauterine contraceptive devices (IUCDs) market is driven by a high number of unintended pregnancies, and favorable government initiatives for spreading awareness and encouraging the use of effective contraceptive methods are projected to have a synergistic effect on intrauterine contraceptive devices (IUCDs) market growth. According to the MRFR analysis, more than 40% of pregnancies in Europe and around 35% in Asia are unplanned, leading to a high demand for intrauterine contraceptive devices (IUCDs).

  • fewer side-effects associated with the use of intrauterine contraceptive devices

  • The emergence of advanced intrauterine contraceptive devices (IUCDs) with high accuracy

  • The implementation of affordable care is also responsible for boosting the growth of the intrauterine contraceptive devices (IUCDs) market during the forecast period.

  • Other benefits other than avoiding pregnancy, such as lighter periods and help in the menstrual cycle is likely to encourage the use of intrauterine contraceptive devices (IUCDs).


Market Restraints




  • Side effects associated with implantation of intrauterine contraceptive devices (IUCDs) such as intrauterine pregnancy and pelvic inflammatory disease (PID) is likely to hamper the growth of the Intrauterine Contraceptive Devices (IUCDs) market during the forecast period.




  • Additionally, Stringent regulatory guidelines and strict reimbursement policies are hindering the growth of the intrauterine contraceptive devices (IUCDs) market.




Intrauterine Contraceptive Devices (IUCDs) MarketSegmentation


By Type




  • Hormonal Intrauterine Device: These devices contain levonorgestrel, which helps to prevent pregnancy by changing the viscosity of cervical mucus to prevent sperm from reaching the egg. It can release levonorgestrel from 16 μg/day to 20 μg/day. These devices are used for 3, 5, or 7 years. Mirena, Skyla, and Liletta are some popular brands of Hormonal Intrauterine Devices. This segment is likely to register the highest CAGR during the forecast period.




  • Copper Intrauterine Device: Copper Intrauterine Devices are traditional devices which are in used since 1988 and considered as one of the most effective contraceptive devices. Paragard is one of the major brands in the copper intrauterine devices segment. Copper is toxic for sperms, and it kills sperms when it tries to enter the uterus. Copper intrauterine devices can be effectively used until ten years. Moreover, the use of copper intrauterine devices can cause heavier menstrual flow and cramps. This segment is expected to lead the intrauterine contraceptive devices (IUCDs) market with maximum market share.




By End-User




  • Hospitals: Hospitals and health centers are expected to be the largest segment because hospitals and health centers are usually the primary points for diagnosis, treatment, and rehabilitation of individuals.




  • Gynecology Clinics: Consisting of long-term and accurate care for patients suffering from medical complications related to gynecology, this is a fast-growing intrauterine contraceptive devices (IUCDs) market segment, especially in developed nations.




  • Community Health Care Centers: A small segment, these centers provide all primary medications and basic healthcare needs.




  • Others: Others segment includes small- and mid-scale healthcare centers, government organizations, and emergency centers.




By Region




  • Asia-Pacific: The Americas is the largest regional market for Intrauterine contraceptive devices (IUCDs), Asia-Pacific has the world’s largest population and a fast-developing healthcare sector. Additionally, the government in countries like India and China are encouraging youth population to use intrauterine contraceptive devices (IUCDs), and it is likely to drive the growth of the intrauterine contraceptive devices (IUCDs) market. For instance, the Chinese government has implanted more than 350 million intrauterine contraceptive devices from 1980 to 2017 as a part of the birth control program.




  • Americas: The Americas is the second-largest regional for intrauterine contraceptive devices (IUCDs) market. An increasing number of unintended pregnancies, rising awareness about benefits of intrauterine contraceptive devices (IUCDs) along with the increasing healthcare expenditure in the region is also likely to drive the growth of the intrauterine contraceptive devices (IUCDs) market during the assessment period.




  • Europe: Europe has some of the best healthcare services in the world. The demand for intrauterine contraceptive devices is high in this region due to the increasing number of healthcare centers in the region and government support along with the rising adoption of new technologies in the healthcare industry.




  • Middle East & Africa: Despite the developing healthcare infrastructure, intrauterine contraceptive devices (IUCDs) are used as a very effective birth control method, which is responsible for the rising demand for intrauterine contraceptive devices (IUCDs) market in the region.




Intrauterine Contraceptive Devices (IUCDs) Market Key Players



  • Bayer AG

  • Eurogine, S.L.

  • The Cooper Companies, Inc.

  • Pfizer Inc.

  • HLL Lifecare Limited

  • OCON Healthcare

  • SMB Corporation

  • Egemen International

  • Meril Life Sciences Pvt. Ltd.

  • Mona Lisa N.V.

  • Prosan International B.V.

  • Pregna International Limited

  • Others



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 2658.2 Million
  CAGR   10.5% (2019-2025)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type and End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Bayer AG, Eurogine, S.L., The Cooper Companies, Inc., Pfizer Inc., HLL Lifecare Limited, OCON Healthcare, SMB Corporation, Egemen International, Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., Prosan International B.V., Pregna International Limited, Others
  Key Market Opportunities   Strategic mergers & acquisitions and new product launches
  Key Market Drivers

  • high number of unintended pregnancies, and favorable government initiatives for spreading awareness
  • Increasing demand for easy to use, removable, and cost-effective contraceptives


  • Frequently Asked Questions (FAQ) :


    The valuation of the global intrauterine contraceptive devices (IUCDs) market is estimated to reach USD 2658.2 MN by 2025.

    The global intrauterine contraceptive devices (IUCDs) market is projected to grow at approximately 10.5% CAGR during the forecast period (2019-2025).

    The technological innovations that are increasing the effectiveness of contraception.

    North America holds the largest share in the global intrauterine contraceptive devices (IUCDs) market, followed by Europe and the Asia Pacific, respectively.

    Eurogine, S.L., Bayer AG, The Cooper Companies, Inc., HLL Lifecare Limited, Pfizer Inc., OCON Healthcare, Egemen International, SMB Corporation, Meril Life Sciences Pvt. Ltd., Prosan International B.V., Mona Lisa N.V., and Pregna International Limited, are some of the major players operating in the intrauterine contraceptive devices (IUCDs) market.



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.